Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
D
Details...
Enter Symbol
ABAXIS, Inc. (NASDAQ: ABAX)
Sector: Medical
Current Price :
$45.35
52 Week Low
$26.61
52 Week High
$48.67
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Press Releases
Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013
Free Research Reports on ABAX, ASH, ELY and HTS Issued by the Bedford Report
Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum
Free Research Reports on ABAX, BBW, ECTE and PMCS Issued by the Bedford Report
Abaxis To Report Third Quarter Fiscal Year 2013 Financial Results Thursday, January 31, 2013
Abaxis Declares Special Cash Dividend of $1.00 Per Share
Abaxis, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference
Abaxis, Inc. to Present at the Stephens Fall Investment Conference
Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Abaxis Announces Exclusive Distribution Agreement with Abbott
Abaxis To Report Second Quarter Fiscal Year 2013 Financial Results Tuesday, October 23, 2012
Abaxis Announces Distribution Agreement with MWI Veterinary Supply
Abaxis Announces Settlement of Patent Litigation With Cepheid
Abaxis Announces the Launch of Kidney Profile Plus Panel
Abaxis, Inc. to Present at CL King's 10th Annual Best Ideas Conference 2012
Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
Abaxis, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
Abaxis Enters Into Definitive Agreement To Deliver 300 Piccolo Xpress Instruments For A Four-Year Drug Clinical Trial
Abaxis, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
Abaxis to Report Fourth Quarter and Fiscal Year 2012 Financial Results Thursday, April 26, 2012
Abaxis, Inc. to Present at the Sidoti & Company Sixteenth Annual Institutional Investor Forum
Abaxis, Inc. to Present at the Raymond James 33rd Annual Institutional Investor Conference
Abaxis, Inc. to Present at the Citi 2012 Global Health Care Conference and RBC Capital Markets' 2012 Healthcare Conference
Abaxis Veterinary Reference Laboratories Now Offering Quantitative Lyme Test
Abaxis Animal Health Announces the Addition of a Feline Heartworm Application to the Rapid Diagnostics Product Line
Abaxis, Inc. to Present at the 23rd Annual Piper Jaffray Health Care Conference
Abaxis, Inc. to Present at Stephens, Inc. 2011 Fall Investment Conference
Abaxis, Inc. to Present at Sidoti & Company's New York II Emerging Growth Institutional Investor Forum
Abaxis to Report Second Quarter Fiscal Year 2012 Financial Results Tuesday, October 25, 2011
Abaxis Announces the Formation of a Clinical Pathology Resident Fund at Kansas State University
Abaxis to Report Second Quarter Fiscal Year 2012 Financial Results Tuesday, October 25, 2011
Abaxis Veterinary Reference Laboratories Now Fully Operational Nationwide
Abaxis, Inc. to Present at 2011 UBS Global Life Sciences Conference
Abaxis, Inc. to Present at CL King's 9th Annual Best Ideas Conference 2011
Abaxis to Present at 2011 Morgan Stanley Global Healthcare Unplugged Conference
Abaxis Announces Stock Repurchase Program
Abaxis to Report First Quarter Fiscal Year 2012 Financial Results Thursday, July 28, 2011
Abaxis Launches Two New Rapid Diagnostic Tests in Veterinary Market
Abaxis to Present at Jefferies' 2011 Global Healthcare Conference
Abaxis to Present at ThinkEquity's Second Annual Healthcare Conference
Abaxis Receives Presidential "E" Award for Exports
Abaxis, Inc. Awarded $650,000 from Kansas Bioscience Authority
Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
Abaxis Appoints Vernon Altman to Board of Directors
Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2011
Abaxis to Report Fourth Quarter and Fiscal Year 2011 Financial Results Thursday, April 28, 2011
Abaxis to Report Fourth Quarter and Fiscal Year 2011 Financial Results Thursday, April 28, 2011
Abaxis, Inc. to Present at the 10th Annual Needham Healthcare Conference
Abaxis, Inc. to Present at RBC Capital Markets' Healthcare Conference
Abaxis, Inc. to Present at the Citi 2011 Global Health Care Conference
Abaxis Makes $2.8 Million Equity Investment in Scandinavian Micro Biodevices APS
Abaxis Reports Financial Performance With Record Sales for the Third Quarter of Fiscal 2011
Abaxis to Report Third Quarter Fiscal 2011 Financial Results Thursday, January 27, 2011
Abaxis Animal Health Poised to Enter Commercial Laboratory Market
Abaxis, Inc. Announces New 10-Year Contract to Supply BD with Patented Orbos? Reagent Beads
Abaxis to Report Third Quarter Fiscal 2011 Financial Results Thursday, January 27, 2011
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##